Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
05 apr 2024
Equity Research Kancera: Rights issue extends run-way at a crucial stage
Equity Research
Kancera
03 apr 2024
Equity Research Svenska Aerogel, Q4 2023: Improved production facilities to boost margins
Equity Research
Svenska Aerogel
03 apr 2024
Carlsquare weekly market letter: Into thin air
Equity Research
Carlsquare
27 mar 2024
Carlsquare weekly market letter: Commodities on the move again
Equity Research
Carlsquare
20 mar 2024
Carlsquare weekly market letter: Inflation on the verge of a comeback
Equity Research
Carlsquare
15 mar 2024
Equity Research Svenska Aerogel, Q4 2023: Increased sales of Quartzene™ and lower than expected costs
Equity Research
Svenska Aerogel
13 mar 2024
Research update Biosergen: Rights issue to fund crucial step for lead project
Equity Research
Biosergen
13 mar 2024
Carlsquare weekly market letter: The IPO window is open again
Equity Research
Carlsquare
11 mar 2024
Equity Research InCoax, Q4 2023: Strong order intake over two quarters
Equity Research
InCoax
08 mar 2024
First Impression InCoax, Q4 2023: Good sales and very strong order intake
Equity Research
InCoax
07 mar 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
06 mar 2024
Carlsquare weekly market letter: The bitcoin rally and why it matters to all of us…
Equity Research
Carlsquare
05 mar 2024
Equity research Zinzino: February sales above our expectations
Equity Research
Zinzino
28 feb 2024
Equity Research Mindark PE, Q4 2023: Adjusted accounting principles contribute to high net revenues
Equity Research
28 feb 2024
Equity research Zinzino, Q4 2023: Dividend signals sustained higher margins
Equity Research
Zinzino
28 feb 2024
Equity Research Enrad, Q4 2023: New orders may pick up later in 2024
Equity Research
Enrad
28 feb 2024
Equity research Candles Scandinavia Q3 2023/2024: Better momentum could trigger rerating
Equity Research
Candles Scandinavia
28 feb 2024
Carlsquare weekly market letter: Weight loss, defence and emerging markets in focus as market seeks next leg up
Equity Research
Carlsquare
27 feb 2024
Equity research Zinzino, Q4 2023: Increased dividend proposed after a strong year
Equity Research
Zinzino
26 feb 2024
Initiation of coverage GIAB: More profitable by focusing on electronics
Equity Research
1
…
14
15
16
17
18
…
64